Latest filing published 04 Mar 2026 for Vanda Pharmaceuticals Inc., €298k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Timothy Williams (senior executive) discloses dealings in Vanda Pharmaceuticals Inc. to SEC (Form 4). The record holds 13 filings, for trades running from 16 August 2021 to 2 March 2026.
On the market, this insider has only sold: 7 sales, €611k in total. Besides market trades, the filings include 6 share grants. So far in 2026, the count stands at no purchases and 1 sale.
The record was last updated on 4 March 2026 with an open-market sale (€298k) in Vanda Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations